Kingworld Medicines Group Ltd. (HK:1110) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Kingworld Medicines Group Ltd. reported a decrease in revenue and profit for the first half of 2024 compared to the same period in 2023, with revenue down by 4.9% and profits for the period falling by 4.4%. The company’s gross profit margin also saw a reduction of 1.9 percentage points. Despite the declines, the company managed a valuation gain on investment properties and shared profits from a joint venture and an associate.
For further insights into HK:1110 stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money